BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31305163)

  • 21. Differentiation between athlete's heart and dilated cardiomyopathy in athletic individuals.
    Millar LM; Fanton Z; Finocchiaro G; Sanchez-Fernandez G; Dhutia H; Malhotra A; Merghani A; Papadakis M; Behr ER; Bunce N; Oxborough D; Reed M; O'Driscoll J; Tome Esteban MT; D'Silva A; Carr-White G; Webb J; Sharma R; Sharma S
    Heart; 2020 Jul; 106(14):1059-1065. PubMed ID: 32341137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating proinflammatory cytokines and N-terminal pro-brain natriuretic peptide significantly decrease with recovery of left ventricular function in patients with dilated cardiomyopathy.
    Ahmad S; Otaal PS; Rai TS; Bahl A; Saikia UN; Manoj RK; Thungapathra M; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Apr; 324(1-2):139-45. PubMed ID: 19107325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
    Kaya MG; Sarli B; Akpek M; Kaya EG; Yarlioglues M; Topsakal R; Lam YY
    Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3.
    Stoica A; Şorodoc V; Lionte C; Jaba IM; Costache I; Anisie E; Tuchiluș C; Rusalim Petriș O; Sîrbu O; Jaba E; Ceasovschih A; Vâţă L; Şorodoc L
    J Int Med Res; 2019 Jan; 47(1):159-172. PubMed ID: 30222016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.
    Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A
    Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of N-terminal pro-brain natriuretic peptide in evaluating early septic cardiac dysfunction in neonates].
    Yang C; Liu F; Han M; Li B; Shen Q; Xu P; Yang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):711-715. PubMed ID: 32684218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease.
    Tuñón J; Higueras J; Tarín N; Cristóbal C; Lorenzo Ó; Blanco-Colio L; Martín-Ventura JL; Huelmos A; Alonso J; Aceña Á; Pello A; Carda R; Asensio D; Mahíllo-Fernández I; López Bescós L; Egido J; Farré J
    PLoS One; 2015; 10(6):e0126741. PubMed ID: 26046344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Di Tano G; Caretta G; De Maria R; Parolini M; Bassi L; Testa S; Pirelli S
    Heart; 2017 Jan; 103(1):71-77. PubMed ID: 27465055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Sarli B; Topsakal R; Kaya EG; Akpek M; Lam YY; Kaya MG
    J Investig Med; 2013 Apr; 61(4):728-32. PubMed ID: 23429699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dilated cardiomyopathy with re-worsening left ventricular ejection fraction.
    Nabeta T; Inomata T; Ishii S; Yazaki M; Fujita T; Iida Y; Ikeda Y; Maekawa E; Naruke T; Koitabashi T; Ako J
    Heart Vessels; 2019 Jan; 34(1):95-103. PubMed ID: 29942977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Clin Chem Lab Med; 2004 Feb; 42(2):159-63. PubMed ID: 15061354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Old markers, new approach to assessment of risk in heart failure.
    Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
    Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy.
    Karatolios K; Chatzis G; Holzendorf V; Störk S; Richter A; Binas D; Schieffer B; Pankuweit S
    Dis Markers; 2018; 2018():2958219. PubMed ID: 30018673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach.
    Geenen LW; Baggen VJM; Koudstaal T; Boomars KA; Eindhoven JA; Boersma E; Roos-Hesselink JW; van den Bosch AE
    Am Heart J; 2019 Feb; 208():91-99. PubMed ID: 30580131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and prognostic relevancy of left ventricular trabeculation assessed by cardiac magnetic resonance in patients with dilated cardiomyopathy.
    Mazurkiewicz Ł; Petryka J; Śpiewak M; Miłosz-Wieczorek B; Małek ŁA; Jasińska A; Jarmus E; Marczak M; Misko J; Grzybowski J
    Kardiol Pol; 2017; 75(8):794-803. PubMed ID: 28541593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Tanalp AC; Gurel E; Cevik C; Mutlu B; Basaran Y
    Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
    Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
    Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.
    Stoltze Gaborit F; Bosselmann H; Kistorp C; Iversen K; Kumler T; Gustafsson F; Goetze JP; Sölétormos G; Tønder N; Schou M
    BMC Cardiovasc Disord; 2016 May; 16():117. PubMed ID: 27246703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.